• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

dementia

Alzheimers dementia brain memory loss
Biotech

Pharma-backed dementia fund raises $269M to invest in therapies

A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund.
James Waldron May 20, 2025 9:48am
Blood pressure monitor next to toy heart

Large trial reveals link between lowered BP and dementia risk

Apr 24, 2025 11:33am
brain

GSK seeks link between shingles vax and lower dementia risk

Mar 25, 2025 5:00am
Brain wrapped in cash money

Investment firm secures $250M to help fund dementia drug R&D

Mar 20, 2025 2:53pm
blood test tube

Samsung backs Alzheimer's blood test developer C2N Diagnostics

Mar 13, 2025 12:15pm
brain pills alzheimers drug reaction down syndrome

Cognition's phase 2 SHIMMER results allow dementia drug to shine

Dec 18, 2024 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings